Sequoia Pharmaceuticals, Inc.
Records under this name other than patents Sequoia Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sequoia Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,540,354 | Diamide inhibitors of cytochrome P450 Lapsed on the fee record Ended Jan 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 10, 2025 | From the USPTO record |
| US 9,403,789 | Benzofuran-containing amino acid inhibitors of cytochrome P450 Lapsed on the fee record Ended Aug 2, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 2, 2024 | From the USPTO record |
| US 9,233,952 | Compositions and methods for inhibiting cytochrome P450 Lapsed on the fee record Ended Jan 12, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 12, 2024 | From the USPTO record |
| US 8,048,871 | Compositions and methods for inhibiting cytochrome P450 Lapsed on the fee record Ended Nov 1, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 1, 2023 | From the USPTO record |
| US 8,952,056 | Methods for inhibiting drug degradation Lapsed on the fee record Ended Feb 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 10, 2023 | From the USPTO record |
| US 8,906,647 | Diamide inhibitors of cytochrome P450 Lapsed on the fee record Ended Dec 9, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 9, 2022 | From the USPTO record |
| US 8,791,157 | 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 Lapsed on the fee record Ended Jul 29, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2022 | From the USPTO record |
| US 9,849,107 | Compositions and methods for inhibiting cytochrome P450 Lapsed on the fee record Ended Dec 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2021 | From the USPTO record |
| US 8,569,364 | 5-substituted benzofurans as inhibitors of cytochrome P450 2D6 Lapsed on the fee record Ended Oct 29, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2021 | From the USPTO record |
| US 8,481,520 | Compositions and methods for inhibiting cytochrome P450 Lapsed on the fee record Ended Jul 9, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2021 | From the USPTO record |